Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tulasi Gummadi"'
Autor:
Bhaskar C. Kolla, Ashley Petersen, Madhuri Chengappa, Tulasi Gummadi, Chitra Ganesan, Wolfgang B. Gaertner, Anne Blaes
Publikováno v:
Cancer Medicine, Vol 9, Iss 10, Pp 3400-3406 (2020)
Abstract Background The impact of using adjuvant chemotherapy following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with appendiceal adenocarcinoma is not known. The aim of this study was to assess th
Externí odkaz:
https://doaj.org/article/f5edd18ba79a4e0bb0ba271ad5adc533
Autor:
Chitra Ganesan, Tulasi Gummadi, Anne H. Blaes, Bhaskar Kolla, Madhuri Chengappa, Ashley Petersen, Wolfgang B. Gaertner
Publikováno v:
Cancer Medicine, Vol 9, Iss 10, Pp 3400-3406 (2020)
Cancer Medicine
Cancer Medicine
Background The impact of using adjuvant chemotherapy following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with appendiceal adenocarcinoma is not known. The aim of this study was to assess the impact
Autor:
Ben Y. Zhang, William F. Elmquist, Arkadiusz Z. Dudek, Chul Kim, Vanna Chiarion-Sileni, Tulasi Gummadi, Lisa A. Kottschade, Jacopo Pigozzo, Rajendar K. Mittapalli, Sara Valpione
Publikováno v:
Melanoma research. 25(1)
The impact of BRAF mutations in metastatic melanoma on the incidence of brain metastases and melanoma prognosis and the effect of BRAF inhibitors on the incidence of brain metastases has not been defined. Therefore, a retrospective analysis of patien
Publikováno v:
Journal of Clinical Oncology. 32:e15182-e15182
e15182 Background: Appendicular carcinoma is a very rare malignant neoplasm of the vermiform appendix. Cytoreduction with hyperthermic intraperitoneal chemotherapy ( HIPEC) continues to be the stan...
Autor:
Tulasi Gummadi, William F. Elmquist, Arkadiusz Z. Dudek, Lisa A. Kottschade, Chul Kim, Roxana S. Dronca, Rajendar K. Mittapalli
Publikováno v:
Web of Science
9048 Background: Brain metastases continue to be the major cause of morbidity and mortality in patients with metastatic melanoma. The impact of BRAF mutations and effectiveness of BRAF inhibitors on the brain metastases in these patients is lacking.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b535cb8f6ec746647ed6994b91c5b12
https://publons.com/wos-op/publon/55160821/
https://publons.com/wos-op/publon/55160821/